IL136828A - CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15) - Google Patents
CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15)Info
- Publication number
- IL136828A IL136828A IL13682898A IL13682898A IL136828A IL 136828 A IL136828 A IL 136828A IL 13682898 A IL13682898 A IL 13682898A IL 13682898 A IL13682898 A IL 13682898A IL 136828 A IL136828 A IL 136828A
- Authority
- IL
- Israel
- Prior art keywords
- toluoylpyrrole
- methyl
- med
- polymorphic form
- crystalline polymorphic
- Prior art date
Links
- GZQHOTPDLORUIU-UHFFFAOYSA-N 2-acetamidoacetic acid;(4-methylphenyl)-(1-methylpyrrol-2-yl)methanone Chemical compound CC(=O)NCC(O)=O.C1=CC(C)=CC=C1C(=O)C1=CC=CN1C GZQHOTPDLORUIU-UHFFFAOYSA-N 0.000 title abstract 2
- 150000002148 esters Chemical class 0.000 title abstract 2
- CWJNMKKMGIAGDK-UHFFFAOYSA-N amtolmetin guacil Chemical compound COC1=CC=CC=C1OC(=O)CNC(=O)CC(N1C)=CC=C1C(=O)C1=CC=C(C)C=C1 CWJNMKKMGIAGDK-UHFFFAOYSA-N 0.000 title 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/323—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97RM000811A IT1297140B1 (it) | 1997-12-24 | 1997-12-24 | Forma cristallina del guaiacil estere dell'acido l-metil-5-p-toluoil- pirrol-2-acetammidoacetico, procedimento per la sua preparazione e |
PCT/IT1998/000363 WO1999033797A1 (en) | 1997-12-24 | 1998-12-16 | NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15) |
Publications (2)
Publication Number | Publication Date |
---|---|
IL136828A0 IL136828A0 (en) | 2001-06-14 |
IL136828A true IL136828A (en) | 2005-08-31 |
Family
ID=11405418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13682898A IL136828A (en) | 1997-12-24 | 1998-12-16 | CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15) |
Country Status (21)
Country | Link |
---|---|
US (1) | US6288241B1 (zh) |
EP (1) | EP1082304B1 (zh) |
JP (1) | JP4693236B2 (zh) |
KR (1) | KR100554704B1 (zh) |
CN (1) | CN1200930C (zh) |
AT (1) | ATE255562T1 (zh) |
AU (1) | AU781283B2 (zh) |
BR (1) | BR9814476A (zh) |
CA (1) | CA2315835C (zh) |
CZ (1) | CZ297132B6 (zh) |
DE (1) | DE69820301T2 (zh) |
DK (1) | DK1082304T3 (zh) |
ES (1) | ES2210853T3 (zh) |
HU (1) | HU228112B1 (zh) |
IL (1) | IL136828A (zh) |
IT (1) | IT1297140B1 (zh) |
PL (1) | PL197768B1 (zh) |
PT (1) | PT1082304E (zh) |
SK (1) | SK284777B6 (zh) |
TR (1) | TR200001867T2 (zh) |
WO (1) | WO1999033797A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113474354A (zh) * | 2019-02-28 | 2021-10-01 | 国立大学法人东京工业大学 | 酰胺的制造方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1210673B (it) * | 1982-02-26 | 1989-09-20 | Medosan Ind Biochimi | Antinfiammatoria amidi pirrolacetiche ad attivita' |
IT1148117B (it) * | 1982-03-05 | 1986-11-26 | Medosan Ind Biochimi | Attivita'antiflogistica,analgesica,antipiretica,mucolitica e seda tiva della tosse dell'1 metil-5-p-tolilpirrol-2-acetato di 2'metossi-fenile |
IT1197688B (it) * | 1983-07-29 | 1988-12-06 | Medosan Ind Biochimi | Attivita' antiflogistica,analgesica,antipiretica ed antiaggregante piastrinica di 1-metil-5-metilbenzoilpirrol-2-acetamido acetanilidi |
IT1278144B1 (it) * | 1995-07-14 | 1997-11-17 | Medosan Ricerca Srl | Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla secrezione gastrica e quindi gastroprotettivo. |
EP1024807B1 (en) * | 1997-08-08 | 2003-04-16 | MEDOSAN RICERCA S.r.l. | Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment |
-
1997
- 1997-12-24 IT IT97RM000811A patent/IT1297140B1/it active IP Right Grant
-
1998
- 1998-12-16 AU AU17828/99A patent/AU781283B2/en not_active Expired
- 1998-12-16 IL IL13682898A patent/IL136828A/xx not_active IP Right Cessation
- 1998-12-16 HU HU0101025A patent/HU228112B1/hu unknown
- 1998-12-16 DE DE69820301T patent/DE69820301T2/de not_active Expired - Lifetime
- 1998-12-16 EP EP98962664A patent/EP1082304B1/en not_active Expired - Lifetime
- 1998-12-16 CA CA002315835A patent/CA2315835C/en not_active Expired - Lifetime
- 1998-12-16 AT AT98962664T patent/ATE255562T1/de active
- 1998-12-16 KR KR1020007006998A patent/KR100554704B1/ko not_active Expired - Lifetime
- 1998-12-16 CZ CZ20002336A patent/CZ297132B6/cs not_active IP Right Cessation
- 1998-12-16 TR TR2000/01867T patent/TR200001867T2/xx unknown
- 1998-12-16 PT PT98962664T patent/PT1082304E/pt unknown
- 1998-12-16 SK SK895-2000A patent/SK284777B6/sk not_active IP Right Cessation
- 1998-12-16 CN CNB988126567A patent/CN1200930C/zh not_active Expired - Lifetime
- 1998-12-16 WO PCT/IT1998/000363 patent/WO1999033797A1/en active IP Right Grant
- 1998-12-16 PL PL341424A patent/PL197768B1/pl unknown
- 1998-12-16 JP JP2000526481A patent/JP4693236B2/ja not_active Expired - Lifetime
- 1998-12-16 ES ES98962664T patent/ES2210853T3/es not_active Expired - Lifetime
- 1998-12-16 DK DK98962664T patent/DK1082304T3/da active
- 1998-12-16 US US09/581,289 patent/US6288241B1/en not_active Expired - Lifetime
- 1998-12-16 BR BR9814476-6A patent/BR9814476A/pt not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG108806A (en) | IIb/IIIa CELL ADHESION INHIIBITORS, METHOD FOR THE PRODUCTION, PHARMACEUTCIAL COMPOSITION AND ADMINISTRATION THEREOF | |
BG103268A (en) | Propionic acid derivatives and their application | |
AU7035094A (en) | New 11-benzaldoxime-estradiene-derivatives, methods for their production and pharmaceuticals containing these substances | |
AU4010395A (en) | Compositions for increased bioavailability of orally delivered therapeutic agents | |
IE792027L (en) | Pyrroloazetidinones | |
HUP0002037A3 (en) | Hydroximic acid derivatives, use of them for producing pharmaceutical compositions suitable for inhibiting matrix metalloproteinas and pharmaceutical compositions containing the compounds | |
EP1175208A4 (en) | COMPOSITION FOR PREVENTION OR TREATMENT OF DEMENTIA CONTAINING A HYDROXYCINNAMIC ACID DERIVATIVE OR AN EXTRACT OF AN ANGELICAE SPECIES CONTAINING SAID ACID | |
AU7035194A (en) | 11-benzaldoxime-17beta-methoxy-17alpha- methoxymethylestradiene-derivatives, methods for their production and pharmaceuticals containing these substances | |
AU4560297A (en) | Pharmaceutical microspheres of valproic acid for oral administration | |
UA35607C2 (uk) | Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання | |
AU1306795A (en) | Anticonvulsant pseudofructopyranose sulfamates | |
AU3176695A (en) | Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid | |
HUT50790A (en) | Process for producing new 3,5-dihydroxycarboxylic acids and derivatives thereof, as well as pharmaceutical compositions and intermediates comprising such compounds | |
AU9270498A (en) | Tricyclic compounds, preparation method and said method intermediates, appl ication as medicines and pharmaceutical compositions containing same | |
AU4878997A (en) | Novel isoxazol derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the novel compounds | |
IL136828A0 (en) | NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETA MIDOACETIC ACID GUAIACYL ESTER (MED 15) | |
AU3950095A (en) | Compositions and methods for detection of 2,4-dichlorophenoxyacetic acid and related compounds | |
AU6058496A (en) | New aminophenylphosphonic acid compounds, process for preparing them and pharmaceutical compositions containing them | |
CA2136071A1 (en) | 2-arylpropionic acid compositions and process for preparing the same | |
AU7470098A (en) | Antithrombotic agents | |
ES8302623A1 (es) | "procedimiento para la preparacion del acido (2',4'-difluoro-4-bifenil)-oxipropionico". | |
UA41981C2 (uk) | Біотинові сполуки, спосіб їх отримання, фармацевтична композиція та спосіб її отримання | |
HUP9800623A3 (en) | Application of (+)-o-demethyl-tramadol for production of oral analgesic pharmaceutical compositions | |
HUT74186A (en) | 8-oxo-5,8-dihydro-6h-dibenzo[a,g]-quinolizin-13-propanoic acid derivatives, process for producing them and use of them for producing pharmaceutical compositions | |
HUP0000080A3 (en) | Phosphonic acid derivatives with metallopeptidase inhibitor activity, process for preparing them and pharmaceutical compositions of the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |